Metro Superspeciality Hospitals Private Limited, a active private limited company, was established on 05 August 2011 in Delhi, Delhi, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85110DL2011PTC223337. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹29.00 Cr and a paid-up capital of ₹18.66 Cr.
Formerly known as Metro Shanti Lifeline Private Limited. It upholds a compliant status. Its leadership includes Purshotam Lal (Managing Director), Punam Lal (Director). Past directors included Pawan Thapar, Doctor Malti Thapar, Shashi Sinha. It holds no open charges and ₹315.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21, Community Centre, Preet Vihar, Delhi, Delhi, 110092.
U85110DL2011PTC223337
223337
05 August 2011
₹29.00 Cr
₹18.66 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Metro Superspeciality Hospitals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Purshotam Lal | Managing Director | 18 Jun 2012 | Current |
| Punam Lal | Director | 18 Jun 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Aug 2015 | Past |
| Pramod Abcsdd | Director | 28 Aug 2015 | Past |
| Pramod Abcsdd | Company Secretary | 10 May 2024 | Past |
| Pramod Abcsdd | Director | 02 Dec 2013 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 29 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Metro Superspeciality Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.25% decrease. The company also saw a substantial improvement in profitability, with a 30.65% increase in profit. The company's net worth dipped by a decrease of 1.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Metro Superspeciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,155,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2021 | Others | ₹235.00 Cr | Satisfied |
| 23 Feb 2021 | Others | ₹15.00 Cr | Satisfied |
| 13 Dec 2016 | Others | ₹65.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Metro Superspeciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Metro Superspeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metro Superspeciality Hospitals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ravi Arora was appointed as a Company Secretary was appointed as a Company Secretary on 26 Apr 2025 & has been associated with this company since 7 months 4 days . was recorded as a recent event.
The activity Metro Superspeciality Hospitals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Metro Superspeciality Hospitals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge registered on 23 Feb 2021 via Charge ID 100425453 with Others was fully satisfied on 17 Dec 2021. was completed.
A charge registered on 23 Feb 2021 via Charge ID 100425458 with Others was fully satisfied on 17 Dec 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 235.00 Cr with Charge ID 100425453 was registered on 23 Feb 2021. was completed.
The CIN of Metro Superspeciality Hospitals Private Limited is U85110DL2011PTC223337.
Metro Superspeciality Hospitals Private Limited is headquartered at 21, Community Centre, Preet Vihar, Delhi, Delhi, 110092.
Metro Superspeciality Hospitals Private Limited was incorporated on 05 August 2011.
The current directors of Metro Superspeciality Hospitals Private Limited are
The primary industry of Metro Superspeciality Hospitals Private Limited is Hospital And Medical Care.
Metro Superspeciality Hospitals Private Limited is unlisted.
The authorized capital of Metro Superspeciality Hospitals Private Limited is ₹29.00 Cr, and the paid-up capital is ₹18.66 Cr.
The compliance status of Metro Superspeciality Hospitals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX